title: Novel Mutations on EGFR Leu792 Potentially Correlate to Acquired Resistance to Osimertinib in Advanced NSCLC.
authors.affiliation: Department of Medical Oncology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, People's Republic of China.
authors.forename: Kai
authors.initials: K
authors.lastname: Chen
authors.affiliation: Department of Oncology, Shanghai Pulmonary Hospital, Cancer Institute of Tongji University Medical School, Shanghai, People's Republic of China.
authors.forename: Fei
authors.initials: F
authors.lastname: Zhou
authors.affiliation: Department of Medical Oncology, Kunshan First People's Hospital Affiliated to Jiangsu University, Kunshan, Jiangsu, People's Republic of China.
authors.forename: Wenxiang
authors.initials: W
authors.lastname: Shen
authors.affiliation: Department of Oncology, Shanghai Pulmonary Hospital, Cancer Institute of Tongji University Medical School, Shanghai, People's Republic of China.
authors.forename: Tao
authors.initials: T
authors.lastname: Jiang
authors.affiliation: Department of Research and Development, Geneseeq Technology Inc., Toronto, Ontario, Canada.
authors.forename: Xue
authors.initials: X
authors.lastname: Wu
authors.affiliation: Department of Research and Development, Geneseeq Technology Inc., Toronto, Ontario, Canada.
authors.forename: Xiaoling
authors.initials: X
authors.lastname: Tong
authors.affiliation: Department of Research and Development, Geneseeq Technology Inc., Toronto, Ontario, Canada.
authors.forename: Yang W
authors.initials: YW
authors.lastname: Shao
authors.affiliation: Department of Radiotherapy, The First Affiliated Hospital of Soochow University, Soochow, Jiangsu, People's Republic of China.
authors.forename: Songbing
authors.initials: S
authors.lastname: Qin
authors.affiliation: Department of Oncology, Shanghai Pulmonary Hospital, Cancer Institute of Tongji University Medical School, Shanghai, People's Republic of China. Electronic address: caicunzhou_dr@163.com.
authors.forename: Caicun
authors.initials: C
authors.lastname: Zhou
mesh_terms: D000178:Acrylamides; D000814:Aniline Compounds; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology; D019008:Drug Resistance, Neoplasm / Q000235:genetics*; D066246:ErbB Receptors / Q000235:genetics*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology; D009154:Mutation; D010879:Piperazines / Q000627:therapeutic use*; D011379:Prognosis; D007211:Indoles; D011743:Pyrimidines
chemical_list: D000178:Acrylamides; D000814:Aniline Compounds; D000970:Antineoplastic Agents; D066246:ErbB Receptors; D010879:Piperazines; C000596361:osimertinib; D007211:Indoles; D011743:Pyrimidines; C512478:EGFR protein, human